Oncology Imaging
CoreLab Partners is the most experienced imaging core lab in oncology drug development research. We have successfully partnered with global industry leaders to assist them in bringing to market, life-enhancing oncology drugs in a timely, cost-efficient manner.
Tumor Expertise
CoreLab Partners' experience in the management of medical images for oncology clinical trials is unrivalled and includes medical expertise in most major oncologic tumor types such as:
- Basal Cell
- Bladder
- Bone Mets
- Breast
- Colon
- Colorectal
- Gastric
- GIST (GI stromal tumors)
- Glioblastoma Multiforme
- Head and Neck
- Liver
- Lung (small & non-small cell)
|
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine
- Ovarian
- Pancreatic
- Prostate
- Renal Cell
- Sarcoma
- Solid Tumors
- Thyroid
|
We employ full-time radiologists, oncologists, and nuclear medicine physicians to deliver accurate, credible medical imaging trial data. Our board-certified radiologists and medical oncologists read all radiographic and photographic images - from baseline to completion.
We have provided Phase II data, pivotal Phase III data, and/or digital FDA image submissions for 22 NDA or SNDA submissions for various critical oncology indications.
Expert Oncology Review
CoreLab Partners’ board-certified radiologists read all radiographic and photographic images from baseline to completion and provide blinded, in-depth oncology response review.
Response Evaluation – Lesion Measurement
CoreLab Partners continually refines and enhances our technological and regulatory expertise, staying conversant with current industry techniques and assessment criteria standards including:
- RECIST and RECIST 1.1
- Cheson (1996, 1999, 2007)
- WHO
- Macdonald
- EBMT
- CHOI
- EORTC (Young, 1999)
- Volumetric Assessment
- RANO
- PERCIST
Therapeutic Expertise
 Whatever your therapeutic area, our experience and expert analysis of complex medical images for clinical studies is unrivaled and supported by our in-house physicians who evaluate imaging data, both qualitatively and quantitatively. We have completed image analysis for clinical studies in a broad range of therapeutic categories including:
- Cardiology
- CNS
- Diabetes
- Diagnostic agents
- Musculoskeletal
- Neurology
- Oncology
Modalities
Our experienced medical staff interprets data from all major modalities including:
- Angiography
- Computed Tomography (CT)
- Dual energy X-ray Absorptiometry (DXA)
- Magnetic Resonance Imaging (MRI)
- Nuclear medicine
- Positron Emission Tomography (PET)
- PET/CT
- Single Photon Emission Computed Tomography (SPECT)
- Ultrasound
- X-Ray
- Medical photography
Medical and Scientific Leadership
CoreLab Partners provides comprehensive medical expertise from protocol development to regulatory submission. Our thought-leader physicians are available for consultation in the planning and implementation of the imaging portion of your protocol, including the identification and selection of optimal response evaluation criteria and modalities for your study.
- Physician involvement from RFP response to study closeout
- Significant collaboration with regulatory agencies in developing independent review standards and submission guidelines
CoreLab Partners' Focus
- Quality, service and results
- Sponsor satisfaction
- Innovative solutions
- On-going process improvement
|